No quarterly revenue total was found in CONEXEU SCIENCES INC.'s SEC filings.
Conexeu Sciences Inc. (CNXU) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. Free cash flow was -$6.8 million. As of Jul 31, 2026 it held $2.0 million in cash and investments and $72,482 in total debt.
Revenue
—
Net income
$-7.73M
-235.3% vs prior quarter
Operating cash flow
$-6.76M
-102.3% vs prior quarter
Free cash flow
$-6.80M
-101.5% vs prior quarter
EPS
$-0.29
-163.6% vs prior quarter
Dividend per share
None
Shares outstanding
28.21M
+5.4% vs prior quarter
Net cash
$1.90M
Q3 FY2026
Operating margin
—
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- CNXU (Nasdaq)
- Fiscal year ends
- October 31
- Incorporated in
- NV
- Headquarters
- Reno, NV
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2066836
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Jul 31, 2026 |
Q2 FY2026 Apr 30, 2026 |
|---|---|---|
| Operating income | -$7.7M | -$2.4M |
| Net income | -$7.7M | -$2.3M |
| Diluted EPS | -$0.29 | -$0.11 |
| Operating cash flow | -$6.8M | -$3.3M |
| Free cash flow | -$6.8M | -$3.4M |
| Total assets | $7.2M | $8.2M |
| Total liabilities | $1.3M | $1.0M |
| Stockholders' equity | $5.9M | $7.2M |
| Cash and investments | $2.0M | $6.8M |
| Total debt | $72,482 | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Unregistered share sale, Other events
|
Oct 27, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Oct 20, 2026 | Oct 15, 2026 |
| 10-Q | Quarterly report | Sep 14, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Sep 10, 2026 | Sep 4, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 7, 2026 | Jul 7, 2026 |
| 10-Q | Quarterly report | Jun 15, 2026 | Apr 30, 2026 |
All 90 Conexeu Sciences Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.